Progestins: pro-senescence therapy for ovarian cancer?

Oesterreich S, Steffi Oesterreich, Edwards R, Robert Edwards, Anda Vlad, Vlad A
Cell cycle (Georgetown, Tex.) · 2013 · vol. 12(11) , pp. 1662–3 · doi:10.4161/cc.25072 · PMID:23708445 · PMC3713123
Other OA: gold CC-BY-NC-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-02 ⓘ

This review discusses progestins' potential role in inducing senescence in ovarian cancer cells and explores their therapeutic implications for the disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Cellular Senescence Forkhead Transcription Factors Ovarian Neoplasms Ovarian Neoplasms Receptors, Progesterone Female Forkhead Transcription Factors Humans Ovarian Neoplasms Receptors, Progesterone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:11:59.585523+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-4.0